Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide
European Journal of Clinical Pharmacology1995Vol. 47(5), pp. 455–60
Citations Over TimeTop 14% of 1995 papers
Jérôme Biollaz, Alain Munafo, Thierry Buclin, Jacopo Gervasoni, Jean‐Luc Magnin, F. Jaquet, Françoise Brunner‐Ferber
Related Papers
- → Carbonic Anhydrase Inhibitors in Ophthalmology: Glaucoma and Macular Oedema(2021)4 cited
- → Heterocyclic compounds as carbonic anhydrase inhibitor(2011)26 cited
- → Variable Involvement of the Perivascular Retinal Tissue in Carbonic Anhydrase Inhibitor–Induced Relaxation of Porcine Retinal Arterioles In Vitro(2007)23 cited
- → Aqueous Humor Flow in Human Eyes Treated With Dorzolamide and Different Doses of Acetazolamide(1998)45 cited
- → Comparison of Intraocular Pressure Lowering by Topical and Systemic Carbonic Anhydrase Inhibitors in the Rabbit(1999)8 cited